These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21886390)

  • 1. Transfusion associated graft versus host disease following whole blood transfusion from an unrelated donor in an immunocompetent patient.
    Patel KK; Patel AK; Ranjan RR; Shah AP
    Indian J Hematol Blood Transfus; 2010 Sep; 26(3):92-5. PubMed ID: 21886390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal graft-versus-host disease associated with transfusions of HLA-matched, HLA-homozygous platelets from unrelated donors.
    Benson K; Marks AR; Marshall MJ; Goldstein JD
    Transfusion; 1994 May; 34(5):432-7. PubMed ID: 8191569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion-associated graft-versus-host disease.
    Rühl H; Bein G; Sachs UJ
    Transfus Med Rev; 2009 Jan; 23(1):62-71. PubMed ID: 19056035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion-associated graft vs. host disease after donor-specific leukocyte transfusion before kidney transplantation.
    van der Mast BJ; van den Dorpel MA; Drabbels JJ; Claas FH; Weimar W
    Clin Transplant; 2003 Oct; 17(5):477-83. PubMed ID: 14703935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transfusion-associated graft-vs-host disease].
    Lillevang ST; Kristensen T
    Ugeskr Laeger; 1992 Oct; 154(43):2964-8. PubMed ID: 1462384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA homozygosity and shared HLA haplotypes in the development of transfusion-associated graft-versus-host disease.
    Shivdasani RA; Anderson KC
    Leuk Lymphoma; 1994 Oct; 15(3-4):227-34. PubMed ID: 7866271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [One-way matching of HLA antigens between recipient and donor as a risk factor of transfusion-associated GVHD].
    Takahashi K
    Nihon Rinsho; 1997 Sep; 55(9):2240-5. PubMed ID: 9301283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How is transfusion-associated graft-versus-host disease similar to, yet different from, organ transplantation-associated graft-versus-host disease?
    Sato N; Marubashi S
    Transfus Apher Sci; 2022 Apr; 61(2):103406. PubMed ID: 35283033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal transfusion-associated graft-versus-host disease with concomitant immune hemolysis in a group A combat trauma patient resuscitated with group O fresh whole blood.
    Gilstad C; Roschewski M; Wells J; Delmas A; Lackey J; Uribe P; Popa C; Jardeleza T; Roop S
    Transfusion; 2012 May; 52(5):930-5. PubMed ID: 21981662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential for transfusion-associated graft-versus-host disease due to apheresis platelets matched for HLA class I antigens.
    Grishaber JE; Birney SM; Strauss RG
    Transfusion; 1993; 33(11):910-4. PubMed ID: 8259596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factors.
    Petz LD; Calhoun L; Yam P; Cecka M; Schiller G; Faitlowicz AR; Herron R; Sayah D; Wallace RB; Belldegrun A
    Transfusion; 1993 Sep; 33(9):742-50. PubMed ID: 8105567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion associated graft versus host disease in an immunocompetent individual following coronary artery bypass grafting.
    Nagendra GT; M N R; Hegde DP; Damodar S; Gupta R
    Indian J Crit Care Med; 2008 Jul; 12(3):124-7. PubMed ID: 19742259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transfusion-associated graft-versus-host disease guideline on gamma irradiation of blood components].
    Landi EP; de Oliveira JS
    Rev Assoc Med Bras (1992); 1999; 45(3):261-72. PubMed ID: 10513059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion-associated graft-versus-host disease in immunocompetent patients: case series and review of the literature.
    Agbaht K; Altintas ND; Topeli A; Gokoz O; Ozcebe O
    Transfusion; 2007 Aug; 47(8):1405-11. PubMed ID: 17655584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion associated graft versus host disease in an immunocompetent individual following coronary artery bypass grafting.
    Ahya R; Douglas JG; Watson HG
    Heart; 1998 Sep; 80(3):299-300. PubMed ID: 9875094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft-versus-host disease: introduction and prospect.
    Ohto H; Suzuki H; Abe R
    Fukushima J Med Sci; 1993 Dec; 39(2):63-7. PubMed ID: 7927136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion associated GVHD.
    Sohi I; Jacob S
    Indian J Pediatr; 2005 Jun; 72(6):533-5. PubMed ID: 15985746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion-associated graft-versus-host disease: an overview and two case reports.
    Spector D
    Oncol Nurs Forum; 1995; 22(1):97-101. PubMed ID: 7708528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of transfusion-associated graft-versus-host disease.
    Kopolovic I; Ostro J; Tsubota H; Lin Y; Cserti-Gazdewich CM; Messner HA; Keir AK; DenHollander N; Dzik WS; Callum J
    Blood; 2015 Jul; 126(3):406-14. PubMed ID: 25931584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion-associated graft-versus-host disease in immunocompetent patients: a self-protective mechanism.
    van der Mast BJ; Hornstra N; Ruigrok MB; Claas FH; van Rood JJ; Lagaaij EL
    Lancet; 1994 Mar; 343(8900):753-7. PubMed ID: 7907730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.